Skip to main content
Gian Life Care Limited Logo

Gian Life Care Limited

Offer PeriodDec 31, 2019 – Jan 03, 2020
Listed Price
₹22.00
+0.00%
Price Band₹22 - ₹22
Lot Size6,000 Shares
Allotment DateJan 08, 2020
Listing DateJan 13, 2020
Subscription-
Issue Size₹3.00 Cr

IPO Details

Subscription

lot distribution

Lot Distribution

reservation

Reservation

company financials

Company Fin.

₹0
(0.00%)

Premium (ELP)

Gian Life Care Limited's successfully completed its Initial Public Offering and commenced trading on Jan 13, 2020 at the BSE exchange. The company raised 14,16,000 Shares through this public offering, comprising TBD in fresh capital.

The IPO was priced within the band of ₹22 to ₹22, with minimum application lots of 6000 shares. The offering attracted significant investor interest during its subscription period from Dec 31, 2019 to Jan 03, 2020.

Share allotment was finalized on Jan 08, 2020, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.

Gian Life IPO Details
IPO Date
:
Dec 31, 2019 to Jan 03, 2020
Allotment Date
:
Jan 08, 2020
List Date
:
Jan 13, 2020
Lot Size
:
6,000 share
Issue Price
:
₹22 - ₹22
Issue Size
:
14,16,000 (aggregating up to 3.00 Cr)
Fresh Issue
:
-
Offer For Sale
:
-
Listing At
:
BSE
Share Holding Pre-Issue
:
32,84,694
Share Holding Post-Issue
:
47,00,694
Market Marker Portion
:
72,000
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Shares14,16,000
Market Maker
5.08%(72,000)
HNI
47.46%(6,72,000)
RETAIL
47.46%(6,72,000)
Total
100.00%(14,16,000)
Gian Life IPO Key Performance Indicators
Company Financials (in Lakhs)
Gian Life IPO About Company

Gian Life Care Limited, founded in 2018 and based in Kanpur, Uttar Pradesh, is a diagnostic and healthcare service provider offering a wide range of tests and health services focused on diagnosis, prevention, and wellness for individuals as well as hospitals and corporate clients. The company provides over 1,344 diagnostic tests covering areas such as biochemistry, clinical pathology, hematology, histopathology, microbiology, molecular biology, immunoassay, cytogenetics, cytology, coagulation, and radiology. Gian Life Care operates as an NABL accredited and ISO 9001:2015 certified organization and is supported by a team of 59 full-time employees.

Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."

Gian Life IPO Strength Factors
  1. Wide diagnostic test portfolio: Provides over 1,344 diagnostic tests covering pathology, molecular biology, cytogenetics, radiology, and preventive healthcare.
  2. Quality accreditations and certifications: NABL accreditation and ISO 9001:2015 certification enhance credibility and service reliability.
  3. Diverse client base: Serves individuals, hospitals, and corporate clients, reducing dependence on a single customer segment.
⚠️Gian Life IPO Risk Factors
  1. Limited operating history: Incorporated in 2018, the company has a relatively short track record compared to established diagnostic chains.
  2. Smaller workforce scale: Supported by 59 full-time employees, which may limit rapid expansion and operational scalability.
  3. Geographical concentration: Operations are primarily based in and around Uttar Pradesh, restricting national-level presence.
🏦Gian Life IPO Lead Manager(s)
Hem Securities Limited
👤Gian Life IPO Promoter(s)
  1. Mr. Arun Kumar Gupta
🏢Gian Life IPO Company Details

Gian Life Care Limited

Phone:91-0512-2531860
address:7/216 (6), Swaroop Nagar, Kanpur-208002
📋Gian Life IPO Registrar

Cameo Corporate Services Limited

Name:Cameo Corporate Services Limited
Phone:91-44-28460390
Gian Life IPO FAQs
IPO Trend Assistant
Online
Powered by IPO Trend